Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Shrestha (Dhulikhel, Nepal), S. Shrestha (Dhulikhel, Nepal), M. Baral (Dhulikhel, Nepal), S. Bhandari (Dhulikhel, Nepal), S. Chand (Dhulikhel, Nepal), P. Dhakal (Dhulikhel, Nepal), R. Tamrakar (Dhulikhel, Nepal), R. Mehta (Dhulikhel, Nepal), N. Vaidhya (Dhulikhel, Nepal), S. Shrestha (Dhulikhel, Nepal), B. Prajapati (Dhulikhel, Nepal), R. Pandey (Dhulikhel, Nepal), A. Shrestha (Dhulikhel, Nepal), H. Shrestha (Dhulikhel, Nepal). Evaluation of inhalation technique in patients using Dry Powder Inhaler (DPI), and the effect of patient education on their techniques- an experience from Nepal. 1004

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs) Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Innovative dry powder inhaler (DPI) shows improved cost-effectiveness compared with current DPIs for asthma therapy in UK primary care Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Ease of use of a two-strip dry powder inhaler (DPI) to deliver fluticasone furoate/vilanterol (FF/VI) and FF alone in asthma Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Late Breaking Abstract - Factors associated with health-status of COPD patients on Dry Powder Inhaler (DPI) maintenance therapy Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Equivalence of an innovative multidose salmeterol/fluticasone dry powder inhaler vs comparator in paediatric asthma Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013 LATE-BREAKING ABSTRACT: Effectiveness of training session on the inhalation technique of the BA-pMDI Autohaler® (containing beclometasone) in daily practice. Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals Year: 2013 Inspiratory flow resistance of marketed dry powder inhalers (DPI) Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 Assessment of patient engagement and adherence with once-daily indacaterol/glycopyrronium/mometasone (IND/GLY/MF) Breezhaler digital companion in asthma: interim analysis from Germany Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 Delivery of medication by breath-actuated nebulizer (BAN) is similar when used with differing inhalation / exhalation ratios: A contrast to breath enhanced nebulizer (BEN) behavior Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Late Breaking Abstract - Dry Powder Inhaler Preference in asthma patients. Results of the DPI PREFER Study Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Cardiovascular safety of extrafine beclomethasone/formoterol (BDP/FF) delivered via a novel dry powder inhaler (NEXThaler®) in COPD patients Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Patients‘ perceptions of asthma inhalers: a national (UK) survey Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005 Valved holding chambers (VHCs) can have different medication delivery performance as a function of delay interval following actuation of the pressurized metered dose inhaler (pMDI) Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Enhanced training on how to use a dry powder inhaler (DPI) improves the inhalation manoeuvre (IM) of patients with asthma (child 6–17 yrs and adult >17 yrs) or COPD and in healthy adults (HA) when they use a Spiromax® (S) and Turbuhaler® (T) DPI Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis) Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018 Late Breaking Abstract - Lung deposition of two different ICS/LABA combinations with Dry Powder Inhaler (DPI) in asthmatic patients using Functional Respiratory Imaging (FRI). Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Clinical evaluation of fluticasone/formoterol twice daily delivered via a single dose dry powder inhaler in patients with persistent asthma Source: International Congress 2016 – Asthma management Year: 2016 Satisfaction survey on the use of breath actuated Inhaler Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 GENebu Project: home nebulizer use and maintenance in Italy Source: Eur Respir J 2001; 18: 758-763 Year: 2001 Patients’ opinion for their inhalation device. An assessment of convenience and use Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013